203 related articles for article (PubMed ID: 25808110)
1. FOXP3+ and CD39+ regulatory T cells in subtypes of cutaneous lupus erythematosus.
Gambichler T; Pätzholz J; Schmitz L; Lahner N; Kreuter A
J Eur Acad Dermatol Venereol; 2015 Oct; 29(10):1972-7. PubMed ID: 25808110
[TBL] [Abstract][Full Text] [Related]
2. Lupus erythematosus tumidus is a separate subtype of cutaneous lupus erythematosus.
Schmitt V; Meuth AM; Amler S; Kuehn E; Haust M; Messer G; Bekou V; Sauerland C; Metze D; Köpcke W; Bonsmann G; Kuhn A
Br J Dermatol; 2010 Jan; 162(1):64-73. PubMed ID: 19712116
[TBL] [Abstract][Full Text] [Related]
3. Cytokine and chemokine ligand expression in cutaneous lupus erythematosus.
Gambichler T; Genc Z; Skrygan M; Scola N; Tigges C; Terras S; Bechara FG; Kreuter A
Eur J Dermatol; 2012; 22(3):319-23. PubMed ID: 22562806
[TBL] [Abstract][Full Text] [Related]
4. The expression pattern of interferon-inducible proteins reflects the characteristic histological distribution of infiltrating immune cells in different cutaneous lupus erythematosus subsets.
Wenzel J; Zahn S; Mikus S; Wiechert A; Bieber T; Tüting T
Br J Dermatol; 2007 Oct; 157(4):752-7. PubMed ID: 17714558
[TBL] [Abstract][Full Text] [Related]
5. Scarring skin lesions of discoid lupus erythematosus are characterized by high numbers of skin-homing cytotoxic lymphocytes associated with strong expression of the type I interferon-induced protein MxA.
Wenzel J; Uerlich M; Wörrenkämper E; Freutel S; Bieber T; Tüting T
Br J Dermatol; 2005 Nov; 153(5):1011-5. PubMed ID: 16225615
[TBL] [Abstract][Full Text] [Related]
6. Comparative analysis of subacute cutaneous lupus erythematosus and chronic cutaneous lupus erythematosus: clinical and immunological study of 270 patients.
Vera-Recabarren MA; García-Carrasco M; Ramos-Casals M; Herrero C
Br J Dermatol; 2010 Jan; 162(1):91-101. PubMed ID: 19785596
[TBL] [Abstract][Full Text] [Related]
7. Characterization of the inflammatory infiltrate and expression of endothelial cell adhesion molecules in lupus erythematosus tumidus.
Kuhn A; Sonntag M; Lehmann P; Megahed M; Vestweber D; Ruzicka T
Arch Dermatol Res; 2002 Mar; 294(1-2):6-13. PubMed ID: 12071156
[TBL] [Abstract][Full Text] [Related]
8. Inflammatory chemokine profiles and their correlations with effector CD4 T cell and regulatory cell subpopulations in cutaneous lupus erythematosus.
Méndez-Flores S; Hernández-Molina G; Azamar-Llamas D; Zúñiga J; Romero-Díaz J; Furuzawa-Carballeda J
Cytokine; 2019 Jul; 119():95-112. PubMed ID: 30903869
[TBL] [Abstract][Full Text] [Related]
9. Immunologic and genetic considerations of cutaneous lupus erythematosus: a comprehensive review.
Yu C; Chang C; Zhang J
J Autoimmun; 2013 Mar; 41():34-45. PubMed ID: 23380467
[TBL] [Abstract][Full Text] [Related]
10. Enhanced type I interferon signalling promotes Th1-biased inflammation in cutaneous lupus erythematosus.
Wenzel J; Wörenkämper E; Freutel S; Henze S; Haller O; Bieber T; Tüting T
J Pathol; 2005 Mar; 205(4):435-42. PubMed ID: 15685590
[TBL] [Abstract][Full Text] [Related]
11. Skin CD4
Zhao Z; Zhu H; Li Q; Liao W; Chen K; Yang M; Long D; He Z; Zhao M; Wu H; Lu Q
J Autoimmun; 2022 Apr; 128():102811. PubMed ID: 35278775
[TBL] [Abstract][Full Text] [Related]
12. Race differences in immunogenetic features and photosensitivity of cutaneous lupus erythematosus from the aspect of Japanese studies.
Furukawa F; Yamamoto Y; Kanazawa N; Muto M
Ann N Y Acad Sci; 2009 Sep; 1173():552-6. PubMed ID: 19758198
[TBL] [Abstract][Full Text] [Related]
13. The classification and diagnosis of cutaneous lupus erythematosus.
Kuhn A; Landmann A
J Autoimmun; 2014; 48-49():14-9. PubMed ID: 24486120
[TBL] [Abstract][Full Text] [Related]
14. [Anticardiolipin antibodies in cutaneous lupus erythematosus. Incidence and importance as a marker of vascular symptoms].
Tebbe B; Orfanos CE
Hautarzt; 1992 Mar; 43(3):130-3. PubMed ID: 1577600
[TBL] [Abstract][Full Text] [Related]
15. Markers in cutaneous lupus erythematosus indicating systemic involvement. A multicenter study on 296 patients.
Tebbe B; Mansmann U; Wollina U; Auer-Grumbach P; Licht-Mbalyohere A; Arensmeier M; Orfanos CE
Acta Derm Venereol; 1997 Jul; 77(4):305-8. PubMed ID: 9228225
[TBL] [Abstract][Full Text] [Related]
16. Low number of regulatory T cells in skin lesions of patients with cutaneous lupus erythematosus.
Franz B; Fritzsching B; Riehl A; Oberle N; Klemke CD; Sykora J; Quick S; Stumpf C; Hartmann M; Enk A; Ruzicka T; Krammer PH; Suri-Payer E; Kuhn A
Arthritis Rheum; 2007 Jun; 56(6):1910-20. PubMed ID: 17530636
[TBL] [Abstract][Full Text] [Related]
17. Ethnic differences in immunogenetic features and photosensitivity of cutaneous lupus erythematosus.
Furukawa F; Muto M
Arch Dermatol Res; 2009 Jan; 301(1):111-5. PubMed ID: 18797890
[TBL] [Abstract][Full Text] [Related]
18. Photoprovocation in cutaneous lupus erythematosus: a multicenter study evaluating a standardized protocol.
Kuhn A; Wozniacka A; Szepietowski JC; Gläser R; Lehmann P; Haust M; Sysa-Jedrzejowska A; Reich A; Oke V; Hügel R; Calderon C; de Vries DE; Nyberg F
J Invest Dermatol; 2011 Aug; 131(8):1622-30. PubMed ID: 21593767
[TBL] [Abstract][Full Text] [Related]
19. Clinical course and prognosis of cutaneous lupus erythematosus.
Tebbe B
Clin Dermatol; 2004; 22(2):121-4. PubMed ID: 15234012
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of disease activity and damage in different subtypes of cutaneous lupus erythematosus using the CLASI.
Bein D; Kuehn E; Meuth AM; Amler S; Haust M; Nyberg F; Sauerland C; Luger TA; Bonsmann G; Kuhn A
J Eur Acad Dermatol Venereol; 2011 Jun; 25(6):652-9. PubMed ID: 20849444
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
